FangyuLei/tatqa huggingface dataset:
Name
Age
Position
Christopher H. Atayan
59
Chairman of the Board, Chief Executive Officer, Director
Andrew C. Plummer
45
President, Chief Financial Officer, Director
Charles J. Schmaderer
50
Vice President, Corporate Controller, Secretary
executive officers of the registrant .
executive officers of our company are appointed by the board of directors and serve at the discretion of the board .
the following table sets forth certain information with respect to all executive officers of our company .
christopher h .
atayan has served in various senior executive positions with the company since march 2006 including his service as chairman of the board since january 2008 and chief executive officer since october 2006 and has been a director of the company since 2004 .
mr .
atayan has served as the senior managing director of slusser associates a private equity and investment banking firm since 1988 and has been engaged in private equity and investment banking since 1982 .
he also serves on the board of eastek holdings llc a manufacturing company .
andrew c .
plummer has served as our president and chief operating officer since october 2018 as our chief financial officer since january 2007 and as our secretary from january 2007 to october 2018 .
from 2004 to 2007 mr .
plummer served our company in various roles including acting chief financial officer corporate controller and manager of sec compliance .
prior to joining our company in 2004 mr .
plummer practiced public accounting primarily with the accounting firm deloitte and touche llp -now deloitte .
charles j .
schmaderer has served as the company ’ s vice president and corporate controller since april 2018 and as secretary since october 2018 .
from 2006 to 2018 mr .
schmaderer served the company in various roles including as the vice president of financial reporting and assistant secretary and as the director of financial and sec reporting .
prior to joining amcon in 2006 mr .
schmaderer practiced public accounting primarily with the accounting firm grant thornton llp and also holds a master of business administration -mba .

Question: Who are the executive officers of the company?
Answer: Christopher H. Atayan Andrew C. Plummer Charles J. Schmaderer
Year Ended December 31,
Year Ended December 31,
Year Ended December 31,
2019
2019
2018
Supplemental disclosure of cash flow information
Income taxes paid
$318
$15
Interest paid
$5,909
$5,885
Interest received
—
13
Noncash investing and financing activities
Purchases of property and equipment (including internal use software)
1,068
529
Assignment of NantHealth Labs (see Note 20)
—
8,956
nanthealth inc .
consolidated statements of cash flows -continued .
-dollars in thousands .
-1 cash and cash equivalents included restricted cash of $ 1136 $ 1136 and $ 350 at december 31 2019 2018 and 2017 included in other assets respectively .
restricted cash consists of funds that are contractually restricted as to usage or withdrawal related to the company ' s security deposits in the form of standby letters of credit for leased facilities .
no amounts have been drawn upon the letters of credit as of december 31 2019 .
the accompanying notes are an integral part of these consolidated financial statements .

Question: What is the average interest paid by the company in 2018 and 2019?
Answer: 5897
2019
2018
£ million
£ million
Work in progress
0.7
0.6
Finished goods¹
3.2
3.9
3.9
4.5
8 .
stocks .
note .
1 .
finished goods in 2018 includes £ 2 .
2 million relating to deferred costs which has been reclassified from prepayments ; see note 1 for further details .
there were no stock write-downs recognised in the period -2018 nil and there were no reversals of prior period stock write-downs -2018 nil .
no stock is carried at fair value less costs to sell -2018 nil .

Question: What was the change in the amount of stocks?
Answer: -0.6
Year Ended December 31,
Year Ended December 31,
Year Ended December 31,
Year Ended December 31,
Year Ended December 31,
2019
2018
2017
2016
2015
(in millions, except per share data)
(in millions, except per share data)
(in millions, except per share data)
(in millions, except per share data)
(in millions, except per share data)
Consolidated Statements of Income Data:
Revenue
$70,697
$55,838
$40,653
$27,638
$17,928
Total costs and expenses(1)
$46,711
$30,925
$20,450
$15,211
$11,703
Income from operations
$23,986
$24,913
$20,203
$12,427
$6,225
Income before provision for income taxes
$24,812
$25,361
$20,594
$12,518
$6,194
Net income
$18,485
$22,112
$15,934
$10,217
$3,688
Net income attributable to Class A and Class B common stockholders
$18,485
$22,111
$15,920
$10,188
$3,669
Earnings per share attributable to Class A and Class B common stockholders:
Basic
$6.48
$7.65
$5.49
$3.56
$1.31
Diluted
$6.43
$7.57
$5.39
$3.49
$1.29
item 6 .
selected financial data .
you should read the following selected consolidated financial data in conjunction with part ii item 7 " management ' s discussion and analysis of financial condition and results of operations " and our consolidated financial statements and the related notes included in part ii item 8 " financial statements and supplementary data " of this annual report on form 10-k .
the consolidated statements of income data for each of the years ended december 31 2019 2018 and 2017 and the consolidated balance sheets data as of december 31 2019 and 2018 are derived from our audited consolidated financial statements included in part ii item 8 " financial statements and supplementary data " of this annual report on form 10-k .
the consolidated statements of income data for the years ended december 31 2016 and 2015 and the consolidated balance sheets data as of december 31 2017 2016 and 2015 are derived from our audited consolidated financial statements except as otherwise noted that are not included in this annual report on form 10-k .
our historical results are not necessarily indicative of our results in any future period .
-1 total costs and expenses include 4840 million 4150 million 3720 million 3220 million and 2970 million of share-based compensation for the years ended december 31 2019 2018 2017 2016 and 2015 respectively .

Question: What is the revenue for 2019 and 2018 respectively?
Answer: $70,697 $55,838
December 31, 2019
December 31, 2018
$
$
Deferred revenues and gains (note 2)
28,612
31,324
Guarantee liabilities
10,113
9,434
Asset retirement obligation
31,068
27,759
Pension liabilities
7,238
4,847
In-process revenue contracts
11,866
17,800
Derivative liabilities (note 16)
51,914
56,352
Unrecognized tax benefits (note 22)
62,958
40,556
Office lease liability – long-term (note 1)
10,254
—
Other
2,325
1,325
216,348
189,397
other long-term liabilities .
in-process revenue contracts .
as part of the company ’ s previous acquisition of fpso units from petrojarl asa -subsequently renamed teekay petrojarl as or teekay petrojarl the company assumed a certain fpso contract with terms that were less favorable than the then prevailing market terms .
at the time of the acquisition the company recognized a liability based on the estimated fair value of this contract and service obligation .
the company is amortizing the remaining liability over the estimated remaining term of its associated contract on a weighted basis based on the projected revenue to be earned under the contract .
amortization of in-process revenue contracts for the year ended december 31 2019 was $ 5 .
9 million -2018 – $ 14 .
5 million 2017 – $ 27 .
2 million which is included in revenues on the consolidated statements of loss .
amortization of in-process revenue contracts following 2019 is expected to be $ 5 .
9 million -2020 $ 5 .
9 million -2021 and $ 5 .
9 million -2022 .

Question: What is the increase/ (decrease) in Asset retirement obligation from December 31, 2019 to December 31, 2018?
Answer: 3309
December 31,
December 31,
December 31,
2019
2019
2018
Accrued advertising expense
$1,774
$1,875
Accrued compensation expense
2,955
2,813
Reserve for member refunds
293
382
Other accrued expenses
2,455
2,266
Deferred rent
—
517
Total accrued expenses and other
$7,477
7,853
accrued expenses and other consist of the following -in thousands : .
at december 31 2019 and 2018 accounts receivable accounts payable and accrued expenses are not measured at fair value ; however the company believes that the carrying amounts of these assets and liabilities are a reasonable estimate of their fair value because of their relative short maturity .

Question: What is the percentage change in the total accrued expenses and other from 2018 to 2019?
Answer: -4.79
June 30,
2019
June 30,
2018
Accounts receivable 
$201,365
$225,167
Allowance for doubtful accounts
(1,054)
(1,478)
Allowance for product returns
(25,897)
(11,266)
Accounts receivable, net 
$174,414
$212,423
accounts receivable .
the following is a summary of accounts receivable -in thousands : .

Question: What was the change in the Allowance for doubtful accounts between 2018 and 2019?
Answer: 424
Fiscal year-end
Fiscal year-end
2019
2018
Useful Life
Land
$19,490
$17,655
Buildings and improvements
173,333
165,535
5 - 40 years
Equipment, furniture and fixtures
389,225
359,721
3 - 10 years
Leasehold improvements
94,878
89,399
shorter of asset life or lease term
676,926
632,310
Accumulated depreciation and amortization
(353,492)
(320,517)
Property and equipment, net
$323,434
$311,793
property and equipment .
property and equipment are stated at cost and are depreciated or amortized using the straight-line method .
cost accumulated depreciation and amortization and estimated useful lives are as follows -dollars in thousands : .

Question: What was the change in Leasehold improvements from 2018 to 2019?
Answer: 5479
Year Ended March 31, 
Year Ended March 31, 
Year Ended March 31, 
2019
2018
2017
(In thousands)
(In thousands)
(In thousands)
Unrecognized tax benefits, beginning of period
$2,735
$2,714
$2,055
Additions based on tax positions related to current year
371
520
730
Additions based on tax positions related to prior years
13
—
—
2017 Tax Act and tax rate re-measurement  
—
(499)
—
Reductions based on tax positions related to prior years  
(17)
—
—
Lapses during the current year applicable to statutes of limitations  
—
—
(71)
Unrecognized tax benefits, end of period
$3,102
$2,735
$2,714
the long-term portion of the company ’ s unrecognized tax benefits at march 31 2019 and 2018 was $ 622000 and $ 619000 respectively of which the timing of the resolution is uncertain .
as of march 31 2019 and 2018 $ 2 .
5 million and $ 2 .
1 million respectively of unrecognized tax benefits had been recorded as a reduction to net deferred tax assets .
as of march 31 2019 the company ’ s net deferred tax assets of $ 6 .
7 million are subject to a valuation allowance of $ 6 .
7 million .
it is possible however that some months or years may elapse before an uncertain position for which the company has established a reserve is resolved .
a reconciliation of unrecognized tax benefits is as follows : .
the unrecognized tax benefit balance as of march 31 2019 of $ 599000 would affect the company ’ s effective tax rate if recognized .

Question: What was the net deferred tax assets in 2019?
Answer: $6.7 million
Fiscal
Fiscal
Fiscal
2019
2018
2017
(in millions)
(in millions)
(in millions)
Gains (losses) recorded in other comprehensive income (loss)
$ 53
$  (25)
$ (20)
Gains (losses) excluded from the hedging relationship (1)
66
21
(58)
foreign currency exchange rate risk .
as part of managing the exposure to changes in foreign currency exchange rates we utilize cross-currency swap contracts and foreign currency forward contracts a portion of which are designated as cash flow hedges .
the objective of these contracts is to minimize impacts to cash flows and profitability due to changes in foreign currency exchange rates on intercompany and other cash transactions .
we expect that significantly all of the balance in accumulated other comprehensive income -loss associated with the cash flow hedge-designated instruments addressing foreign exchange risks will be reclassified into the consolidated statement of operations within the next twelve months .
during fiscal 2015 we entered into cross-currency swap contracts with an aggregate notional value of € 1000 million to reduce our exposure to foreign currency exchange rate risk associated with certain intercompany loans .
under the terms of these contracts which have been designated as cash flow hedges we make interest payments in euros at 3 .
50 % per annum and receive interest in u .
s .
dollars at a weighted-average rate of 5 .
33 % per annum .
upon the maturity of these contracts in fiscal 2022 we will pay the notional value of the contracts in euros and receive u .
s .
dollars from our counterparties .
in connection with the cross-currency swap contracts both counterparties to each contract are required to provide cash collateral .
at fiscal year end 2019 these cross-currency swap contracts were in an asset position of $ 19 million and were recorded in other assets on the consolidated balance sheet .
the cross-currency swap contracts were in a liability position of $ 100 million and were recorded in other liabilities on the consolidated balance sheet at fiscal year end 2018 .
at fiscal year end 2019 and 2018 collateral received from or paid to our counterparties approximated the derivative positions and was recorded in accrued and other current liabilities -when the contracts are in an asset position or prepaid expenses and other current assets -when the contracts are in a liability position on the consolidated balance sheets .
the impacts of these cross-currency swap contracts were as follows : .
-1 gains and losses excluded from the hedging relationship are recognized prospectively in selling general and administrative expenses and are offset by losses and gains generated as a result of re-measuring certain intercompany loans to the u .
s .
dollar .

Question: What are the components of the impacts of cross-currency swap contracts in the table?
Answer: Gains (losses) recorded in other comprehensive income (loss) Gains (losses) excluded from the hedging relationship
Cost of revenue
Sales and marketing
Research and development
General and administrative
Total restructuring expense
Employee severance and related payroll taxes
$28
$1,355
$340
$194
$1,917
Facilities closure expenses
.
435
89
524
Legal fees
.
.
.
89
89
$28
$1,790
$429
$283
$2,530
restructuring expense .
in october 2019 we began implementing a restructuring plan in our ongoing efforts to reduce operating costs and focus on advanced technologies .
the restructuring plan when complete is expected to result in a workforce reduction of approximately 5 % of our workforce and the closure and consolidation of certain u .
s .
and international office facilities .
we expect to complete the restructuring by the end of the second fiscal quarter of 2020 .
we recorded restructuring expenses of $ 2 .
5 million in the fourth quarter of 2019 which included the following -in thousands .
as of december 31 2019 we had accrued but unpaid restructuring costs of $ 1 .
5 million included in accrued liabilities on the consolidated balance sheets .

Question: What is the total legal fees and facilities expenses?
Answer: 613
Fiscal 2019
Fiscal 2019
Fiscal 2018
Fiscal 2018
Amount
Percentage of total net sales
Amount
Percentage of total net sales
(Dollars in thousands)
Research and development
$117,353
8.2%
$132,586
7.0%
Selling, general and administrative
272,257
19.0%
293,632
15.4%
Impairment and other charges
—
—%
766
—%
Amortization of intangible assets
13,760
1.0%
10,690
0.6%
Total operating expenses
$403,370
28.2%
$437,674
23.0%
operating expenses .
the following table sets forth for the periods indicated the amount of operating expenses and their relative percentages of total net sales by the line items reflected in our consolidated statement of operations -dollars in thousands : .

Question: What was  Amortization of intangible assets  in 2018?
Answer: 10,690
Year Ended December 31,
Year Ended December 31,
Year Ended December 31,
2019
2018
2017
$
$
$
Net loss attributable to shareholders of Teekay Corporation for basic loss per share
(310,577)
(79,237)
(163,276)
Reduction in net earnings due to dilutive impact of stock-based compensation in Teekay LNG, Altera and Teekay Tankers and stock purchase warrants in Altera
—
—
(90)
Net loss attributable to shareholders of Teekay Corporation for diluted loss per share
(310,577)
(79,237)
(163,366)
Weighted average number of common shares
100,719,224
99,670,176
86,335,473
Dilutive effect of stock-based compensation
—
—
—
Common stock and common stock equivalents
100,719,224
99,670,176
86,335,473
Loss per common share - basic and diluted
(3.08)
(0.79)
(1.89)
20 .
net loss per share .
the company intends to settle the principal of the convertible notes in cash on conversion and calculates diluted earnings per share using the treasury-stock method .
stock-based awards and the conversion feature on the convertible notes that have an anti-dilutive effect on the calculation of diluted loss per common share are excluded from this calculation .
for the years ended december 31 2019 2018 and 2017 the number of common stock from stock-based awards and the conversion feature on the convertible notes that had an anti-dilutive effect on the calculation of diluted earnings per common share were 3 .
5 million 4 .
0 million and 3 .
6 million respectively .
in periods where a loss attributable to shareholders has been incurred all stock-based awards and the conversion feature on the convertible notes are anti-dilutive .
-all tabular amounts stated in thousands of u .
s .
dollars other than share data and unless otherwise indicated .

Question: What is the change in Weighted average number of common shares from 2018 to 2019?
Answer: 1049048
Year Ended
Year Ended
Year Ended
April 26, 2019
April 27, 2018
April 28, 2017
Net revenues
$ 6,146
$ 5,919
$ 5,491
Gross profit
$ 3,945
$ 3,709
$ 3,364
Gross profit margin percentage
64 %
63%
61 %
Income from operations
$ 1,221
$ 1,158
$ 621
Income from operations as a percentage of net revenues
20%
20%
11 %
Provision for income taxes
$ 99
$ 1,083
$ 140
Net income
$ 1,169
$ 116
$ 481
Diluted net income per share
$ 4.51
$ 0.42
$ 1.71
Operating cash flows
$ 1,341
$ 1,478
$ 986
financial results and key performance metrics overview .
the following table provides an overview of some of our key financial metrics for each of the last three fiscal years -in millions except per share amounts percentages and cash conversion cycle : .
• net revenues : our net revenues increased 4 % in fiscal 2019 compared to fiscal 2018 .
this was primarily due to an increase of 7 % in product revenues partially offset by a 3 % decrease in software and hardware maintenance and other services revenues .
• gross profit margin percentage : our gross profit margin as a percentage of net revenues increased by one percentage point in fiscal 2019 compared to fiscal 2018 reflecting an increase in gross profit margin on product revenues and to a lesser extent an increase in gross profit margin on hardware maintenance and other services revenues .
• income from operations as a percentage of net revenues : our income from operations as a percentage of net revenues remained relatively flat in fiscal 2019 compared to fiscal 2018 .
• provision for income taxes : our provision for income taxes decreased significantly in fiscal 2019 compared to fiscal 2018 as significant charges were recorded in fiscal 2018 in connection with u .
s .
tax reform .
• net income and diluted income per share : the increase in both net income and diluted net income per share in fiscal 2019 compared to fiscal 2018 reflect the factors discussed above .
diluted net income per share was favorably impacted by a 6 % decrease in the annual weighted average number of dilutive shares primarily due to share repurchases .
• operating cash flows : operating cash flows decreased by 9 % in fiscal 2019 compared to fiscal 2018 reflecting changes in operating assets and liabilities partially offset by higher net income .

Question: What was the income from operations in 2017?
Answer: 621
Three Months Ended
Three Months Ended
Three Months Ended
Three Months Ended
Three Months Ended
March 31,
June 30,
September 30,
December 31,
Year Ended December 31,
2018:
Operating revenues
$1,741.8
$1,780.9
$1,785.5
$2,131.9
$7,440.1
Costs of operations (1)
519.9
560.3
556.7
540.9
2,177.8
Operating income
402.9
546.0
567.2
388.9
1,905.0
Net income
280.3
314.4
377.3
292.7
1,264.7
Net income attributable to American Tower Corporation stockholders
285.2
306.7
366.9
277.6
1,236.4
Dividends on preferred stock
(9.4)
—
—
—
(9.4)
Net income attributable to American Tower Corporation common stockholders
275.8
306.7
366.9
277.6
1,227.0
Basic net income per share attributable to American Tower Corporation common stockholders
0.63
0.69
0.83
0.63
2.79
Diluted net income per share attributable to American Tower Corporation common stockholders
0.63
0.69
0.83
0.62
2.77
american tower corporation and subsidiaries notes to consolidated financial statements -tabular amounts in millions unless otherwise disclosed .
23 .
selected quarterly financial data -unaudited .
selected quarterly financial data for the years ended december 31 2019 and 2018 is as follows -in millions except per share data : .
-1 represents operating expenses exclusive of depreciation amortization and accretion selling general administrative and development expense and other operating expenses .

Question: What was the net income at the end of March 31?
Answer: 280.3
Year Ended December 31,
Year Ended December 31,
Year Ended December 31,
Year Ended December 31,
Year Ended December 31,
(In thousands)
2019
2018
2017
2019 % Change from 2018
2018 % Change from 2017
Revenue
$161,216
$140,326
$69,879
14.9%
100.8%
Gross profit
$104,896
$100,708
$43,817
4.2%
129.8%
Gross margin %
65.1%
71.8%
62.7%
Income from operations
$43,996
$43,641
$23,816
0.8%
83.2%
Operating margin %
27.3%
31.1%
34.1%
veradigm .
our veradigm segment derives its revenue from the provision of data-driven clinical insights with actionable tools for clinical workflow research analytics and media .
its solutions targeted at key healthcare stakeholders help improve the quality efficiency and value of healthcare delivery – from biopharma to health plans healthcare providers and patients and health technology partners among others .
year ended december 31 2019 compared with the year ended december 31 2018 .
veradigm revenue increased during the year ended december 31 2019 compared with the prior year comparable period due to an increase in organic sales .
gross profit and income from operations increased for during the year ended december 31 2019 due to an increase in organic sales and cost reductions partially offset with headcount growth and hosting migration costs .
the acquisition of practice fusion during the first quarter of 2018 also contributed to the increases .
gross margin and operating margin decreased during the year ended december 31 2019 compared with the prior year comparable period primarily due to -i an increase in hosting migration costs -ii costs associated with recent acquisitions -iii headcount growth and -iv partially offset with other cost reductions .
year ended december 31 2018 compared with the year ended december 31 2017 .
veradigm revenue gross profit gross margin and income from operations increased during the year ended december 31 2018 compared with the prior year comparable period primarily due to the acquisition of practice fusion during the first quarter of 2018 .
operating margin decreased during 2018 primarily due to higher personnel costs related to incremental resources from the practice fusion acquisition and to support anticipated new hosting client golives .

Question: What led to decrease in Gross margin and operating margin during the year ended December 31, 2019?
Answer: (i) an increase in hosting migration costs, (ii) costs associated with recent acquisitions, (iii) headcount growth and (iv) partially offset with other cost reductions.